UroGen Pharma Ltd.
(URGN)
undefined
undefined%
At close: undefined
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Cash & Equivalents | 95.00M | 55.41M | 44.36M | 103.91M | 49.69M | 101.32M | 37.00M | 21.36M | 17.98M | 3.87M | 3.04M |
Short-Term Investments | 41.97M | 44.56M | 44.78M | 49.15M | 97.39M | - | 36.00M | - | - | - | - |
Long-Term Investments | 4.50M | 223.00K | 675.00K | 1.89M | 48.55M | 51.00K | 29.00K | 24.00K | - | - | - |
Other Long-Term Assets | 2.26M | 2.74M | 1.53M | 289.00K | 487.00K | 317.00K | 244.00K | 250.00K | - | - | - |
Receivables | 15.44M | 12.70M | 11.72M | 7.05M | - | - | - | 83.00K | - | - | - |
Inventory | 5.67M | 4.33M | 4.83M | 1.96M | - | - | 316.00K | 105.00K | - | - | - |
Other Current Assets | 11.10M | 11.91M | 8.70M | 4.59M | 1.56M | 925.00K | 1.16M | 491.00K | 1.16M | 418.00K | 111.00K |
Total Current Assets | 169.19M | 128.91M | 114.39M | 115.62M | 148.63M | 102.24M | 74.47M | 22.04M | 19.13M | 4.29M | 3.15M |
Property-Plant & Equipment | 2.36M | 3.75M | 3.15M | 4.20M | 4.71M | 948.00K | 805.00K | 741.00K | 259.00K | 71.00K | 77.00K |
Goodwill & Intangibles | - | - | - | - | - | - | - | - | - | - | - |
Total Long-Term Assets | 9.13M | 6.71M | 5.36M | 6.39M | 53.75M | 1.32M | 1.08M | 1.01M | 259.00K | 71.00K | 77.00K |
Total Assets | 178.31M | 136.24M | 119.75M | 122.00M | 202.39M | 103.56M | 75.55M | 23.06M | 19.39M | 4.36M | 3.23M |
Account Payables | 6.51M | 5.53M | 5.79M | 3.27M | 4.69M | 4.27M | 2.84M | 1.88M | 1.72M | 513.00K | 334.00K |
Deferred Revenue | - | 618.00K | 497.00K | 382.00K | - | - | 650.00K | - | - | - | - |
Short-Term Debt | - | 941.00K | - | - | - | - | - | - | - | - | - |
Other Current Liabilities | 24.70M | 17.45M | 16.59M | 18.16M | 14.79M | 9.19M | 3.55M | 1.26M | 521.00K | 378.00K | 150.00K |
Total Current Liabilities | 31.21M | 23.92M | 22.38M | 21.44M | 19.48M | 13.46M | 7.04M | 3.14M | 2.24M | 891.00K | 484.00K |
Long-Term Debt | 99.39M | 99.12M | 398.00K | 1.50M | 2.60M | - | - | - | - | - | - |
Other Long-Term Liabilities | 112.92M | 101.94M | 88.56M | 2.72M | - | - | - | 3.61M | 872.00K | - | - |
Total Long-Term Liabilities | 212.31M | 201.06M | 88.95M | 4.21M | 2.60M | - | - | 3.61M | 872.00K | - | - |
Total Liabilities | 243.52M | 224.98M | 111.33M | 25.65M | 22.09M | 13.46M | 7.04M | 6.75M | 3.11M | 891.00K | 484.00K |
Total Debt | 100.21M | 99.12M | 398.00K | 1.50M | 2.60M | - | - | - | - | - | - |
Common Stock | 89.00K | 63.00K | 61.00K | 60.00K | 57.00K | 44.00K | 37.00K | 6.00K | 6.00K | 2.00K | 2.00K |
Retained Earnings | -679.35M | -577.10M | -467.32M | -356.50M | -228.02M | -122.87M | -47.21M | -27.21M | -25.27M | -12.58M | -8.11M |
Comprehensive Income | 12.00K | -107.00K | -25.00K | 271.00K | 276.00K | -747.00K | -577.00K | -370.00K | -157.00K | - | 0.00 |
Shareholders Equity | -65.21M | -88.74M | 8.41M | 96.36M | 180.30M | 90.09M | 68.52M | 16.31M | 16.28M | 3.47M | 2.74M |
Total Investments | 46.47M | 44.56M | 45.45M | 51.05M | 145.94M | 51.00K | 36.00M | 24.00K | - | - | - |